WHO ICTRP trial
Efficacy of systemic zinc sulphate in prevention of chemotherapy-induced…
IRCT2013042312510N2 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT2013042312510N2 |
|---|---|
| Public title | Efficacy of systemic zinc sulphate in prevention of chemotherapy-induced mucositis in patients with leukemia |
| Scientific title | Efficacy of systemic zinc sulphate in prevention of chemotherapy-induced mucositis in patients with leukemia |
| Primary sponsor | Vice chancellor for research, Tabriz University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Countries | Iran (Islamic Republic of) |
| Conditions | Leukemia. Plasmacytic leukemia;Plasmacytic leukemia |
| Interventions | Intervention 1: Prescription of zinc sulphate(PO) in case group byoncologist during chemotherapy protocol with 220mg/kg dosage would be performed. Intervention 2: prescription of Multivitamin drug(PO) in control group by oncologist during… |
| Registration date | Aug 3, 2013 |
| Target size | 140 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: